← Back to Search

Other

Moisturizing Cream for Radiation Dermatitis

N/A

Waitlist Available

Research Sponsored by Entrinsic Bioscience Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Planned radiotherapy, as prescribed by the oncologist, is expected to provide a total radiation dose of up to 60 gray within the first 4 weeks of treatment

Aged over 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial will test a new moisturizer to see if it can help reduce skin redness from radiation therapy for breast cancer. Participants will use it daily during their treatment.

Who is the study for?

This trial is for adults over 18 with breast cancer who are undergoing radiation therapy, expected to receive up to 60 gray in the first 4 weeks. They must be able to follow daily skin care as per protocol and have no pre-existing skin conditions like eczema or psoriasis that could affect the study.Check my eligibility

What is being tested?

Researchers are testing a new amino acid based moisturizing cream against standard skincare during radiation therapy. The goal is to see if this cream can better reduce skin redness from treatment. Participants will apply it daily alongside their prescribed radiotherapy.See study design

What are the potential side effects?

Potential side effects may include local skin reactions such as increased redness, itching, or irritation at the site of application due to sensitivity towards ingredients in either the novel moisturizer or standard products used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My treatment plan includes up to 60 gray of radiation in the first 4 weeks.

Select...

I am over 18 years old.

Select...

I have breast cancer and am prescribed radiotherapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reduction in Erythema

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Investigational ProductActive Control1 Intervention

Investigational product

Group II: Standard of CarePlacebo Group1 Intervention

Standard of Care

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Entrinsic Bioscience Inc.Lead Sponsor

7 Previous Clinical Trials

702 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently seeking participants for this experiment?

"Based on information from clinicaltrials.gov, this research is not currently enrolling patients; however, it was last edited on August 23rd 2023. For those interested in participating in a study, 16 other trials are actively recruiting participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy

2023. "Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06016361.